1. Home
  2. BAFN vs PMVP Comparison

BAFN vs PMVP Comparison

Compare BAFN & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BAFN
  • PMVP
  • Stock Information
  • Founded
  • BAFN 1999
  • PMVP 2013
  • Country
  • BAFN United States
  • PMVP United States
  • Employees
  • BAFN N/A
  • PMVP N/A
  • Industry
  • BAFN Savings Institutions
  • PMVP Medicinal Chemicals and Botanical Products
  • Sector
  • BAFN Finance
  • PMVP Health Care
  • Exchange
  • BAFN Nasdaq
  • PMVP Nasdaq
  • Market Cap
  • BAFN 65.2M
  • PMVP 55.1M
  • IPO Year
  • BAFN N/A
  • PMVP 2020
  • Fundamental
  • Price
  • BAFN $14.52
  • PMVP $1.15
  • Analyst Decision
  • BAFN
  • PMVP Strong Buy
  • Analyst Count
  • BAFN 0
  • PMVP 1
  • Target Price
  • BAFN N/A
  • PMVP $5.00
  • AVG Volume (30 Days)
  • BAFN 14.1K
  • PMVP 278.5K
  • Earning Date
  • BAFN 07-29-2025
  • PMVP 08-07-2025
  • Dividend Yield
  • BAFN 2.20%
  • PMVP N/A
  • EPS Growth
  • BAFN 116.26
  • PMVP N/A
  • EPS
  • BAFN 2.37
  • PMVP N/A
  • Revenue
  • BAFN $80,167,000.00
  • PMVP N/A
  • Revenue This Year
  • BAFN N/A
  • PMVP N/A
  • Revenue Next Year
  • BAFN N/A
  • PMVP N/A
  • P/E Ratio
  • BAFN $6.12
  • PMVP N/A
  • Revenue Growth
  • BAFN 2.60
  • PMVP N/A
  • 52 Week Low
  • BAFN $11.66
  • PMVP $0.81
  • 52 Week High
  • BAFN $19.75
  • PMVP $1.82
  • Technical
  • Relative Strength Index (RSI)
  • BAFN 48.06
  • PMVP 57.96
  • Support Level
  • BAFN $13.85
  • PMVP $0.96
  • Resistance Level
  • BAFN $14.95
  • PMVP $1.14
  • Average True Range (ATR)
  • BAFN 0.70
  • PMVP 0.07
  • MACD
  • BAFN 0.02
  • PMVP -0.00
  • Stochastic Oscillator
  • BAFN 65.35
  • PMVP 65.28

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

Share on Social Networks: